Literature DB >> 14401265

Hereditary persistence of fetal hemoglobin. A family study.

E C HERMAN, C L CONLEY.   

Abstract

Keywords:  HEMOGLOBIN

Mesh：

Substances：

Year:  1960        PMID： 14401265     DOI： 10.1016/0002-9343(60)90003-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  15 in total

Review 1.  HUMAN HAEMOGLOBINS.

Authors:  E R HUEHNS; E M SHOOTER
Journal:  J Med Genet       Date:  1965-03       Impact factor: 6.318

2.  The effect of methemoglobin formation in sickle cell disease.

Authors:  E BEUTLER
Journal:  J Clin Invest       Date:  1961-10       Impact factor: 14.808

3.  The frequency of elevations in the A and fetal hemoglobin fractions in the natives of Liberia and adjacent regions, with data on haptoglobin and transferrin types.

Authors:  J V NEEL; A R ROBINSON; W W ZUELZER; F B LIVINGSTONE; H E SUTTON
Journal:  Am J Hum Genet       Date:  1961-06       Impact factor: 11.025

4.  Two families showing interaction of haemoglobin C or thalassaemia with high foetal haemoglobin in adults.

Authors:  A P KRAUS; B KOCH; L BURCKETT
Journal:  Br Med J       Date:  1961-05-20

5.  National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.

Authors:  Maureen M Okam; Shimon Shaykevich; Benjamin L Ebert; Alan M Zaslavsky; John Z Ayanian
Journal:  Med Care       Date:  2014-07       Impact factor: 2.983

Review 6.  Customizing the genome as therapy for the β-hemoglobinopathies.

Authors:  Matthew C Canver; Stuart H Orkin
Journal:  Blood       Date:  2016-04-06       Impact factor: 22.113

7.  Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro.

Authors:  D Roa; P Kopsombut; M P Aguinaga; E A Turner
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

8.  Retinal changes in sickle cell/hereditary persistence of fetal haemoglobin syndrome.

Authors:  J F Talbot; A C Bird; G R Serjeant
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

9.  Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.

Authors:  S Charache; G Dover; K Smith; C C Talbot; M Moyer; S Boyer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.

Authors:  Jeffrey D Lebensburger; Tamara I Pestina; Russell E Ware; Kelli L Boyd; Derek A Persons
Journal:  Haematologica       Date:  2010-04-07       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.